Phase I safety and pharmacokinetic trials of 1263W94, a novel oral anti-human cytomegalovirus agent, in healthy and human immunodeficiency virus-infected subjects (Q39743346)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Phase I safety and pharmacokinetic trials of 1263W94, a novel oral anti-human cytomegalovirus agent, in healthy and human immunodeficiency virus-infected subjects	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PMC publication ID

152490

retrieved

14 September 2017

title

Phase I safety and pharmacokinetic trials of 1263W94, a novel oral anti-human cytomegalovirus agent, in healthy and human immunodeficiency virus-infected subjects (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

152490

retrieved

14 September 2017

main subject

phase I clinical trial

0 references

Cytomegalovirus

0 references

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Laurene H Wang

series ordinal

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

152490

retrieved

14 September 2017

Richard W Peck

series ordinal

2

1 reference

stated in

Europe PubMed Central

PMC publication ID

152490

retrieved

14 September 2017

Yin Yin

series ordinal

3

1 reference

stated in

Europe PubMed Central

PMC publication ID

152490

retrieved

14 September 2017

Jane Allanson

series ordinal

4

1 reference

stated in

Europe PubMed Central

PMC publication ID

152490

retrieved

14 September 2017

Rebecca Wiggs

series ordinal

5

1 reference

stated in

Europe PubMed Central

PMC publication ID

152490

retrieved

14 September 2017

Mary Beth Wire

series ordinal

6

1 reference

stated in

Europe PubMed Central

PMC publication ID

152490

retrieved

14 September 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

stated in

Europe PubMed Central

PMC publication ID

152490

retrieved

14 September 2017

published in

Antimicrobial Agents and Chemotherapy

1 reference

stated in

Europe PubMed Central

PMC publication ID

152490

retrieved

14 September 2017

volume

47

1 reference

stated in

Europe PubMed Central

PMC publication ID

152490

retrieved

14 September 2017

issue

4

1 reference

stated in

Europe PubMed Central

PMC publication ID

152490

retrieved

14 September 2017

page(s)

1334-1342

1 reference

stated in

Europe PubMed Central

PMC publication ID

152490

retrieved

14 September 2017

cites work

Diagnosis and treatment approaches of CMV infections in adult patients

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=152490

retrieved

14 September 2017

Phase I dose escalation trial evaluating the pharmacokinetics, anti-human cytomegalovirus (HCMV) activity, and safety of 1263W94 in human immunodeficiency virus-infected men with asymptomatic HCMV shedding

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=152490

retrieved

14 September 2017

Preclinical and toxicology studies of 1263W94, a potent and selective inhibitor of human cytomegalovirus replication

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=152490

retrieved

14 September 2017

Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=152490

retrieved

14 September 2017

Congenital cytomegalovirus infection: review of the epidemiology and outcome

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=152490

retrieved

14 September 2017

Management of cytomegalovirus infection and disease after solid-organ transplantation

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=152490

retrieved

14 September 2017

Synthesis and evaluation of a series of 2'-deoxy analogues of the antiviral agent 5,6-dichloro-2-isopropylamino-1-(beta-L-ribofuranosyl)-1H-benzimidazole (1263W94)

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=152490

retrieved

14 September 2017

The 2001 Garrod lecture. The treatment of cytomegalovirus infection

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=152490

retrieved

20 August 2018

Identifiers

DOI

10.1128/AAC.47.4.1334-1342.2003

1 reference

stated in

Europe PubMed Central

PMC publication ID

152490

retrieved

14 September 2017

PMC publication ID

152490

1 reference

stated in

Europe PubMed Central

PMC publication ID

152490

retrieved

14 September 2017

PubMed publication ID

12654667

1 reference

stated in

Europe PubMed Central

PMC publication ID

152490

retrieved

14 September 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39743346&oldid=2143307614"